Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Prognosis Stories

2010-12-20 09:00:00

CAMBRIDGE, Mass. and BRANFORD, Conn., Dec. 20, 2010 /PRNewswire/ -- Metamark Genetics, Inc., a privately held oncology-focused molecular diagnostics company, and HistoRx, Inc., a diagnostics company developing tissue-based diagnostic solutions to advance individualized patient care, today announced a multi-year licensing agreement. HistoRx has granted Metamark a worldwide license to the AQUA technology for the clinical commercialization of Metamark's proprietary MetamarkDx(TM) Prognostic...

4b89862c68075b35e806dca167b0560a
2010-07-01 06:00:00

A new study finds that families of people who are critically ill may have a more hopeful view their loved one's condition than do doctors, even when doctors provide survival estimates. The study is not the first to show that doctors and family members often differ in their opinions about survival probabilities of critically ill patients, raising doubts about whether doctors are effectively communicating prognoses. Some experts say doctors should provide specific numerical estimates of a...

2009-06-24 08:35:00

 Almost 60 mantle cell lymphoma (MCL) specialists from around the world gathered in Atlanta, GA for the Lymphoma Research Foundation's (LRF) Sixth Annual Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop. Attendees heard presentations addressing several key issues including the biology of MCL, prognostic indicators, new molecular targets, chemoimmunotherapy, transplantation and novel therapeutic approaches.The MCLC was established by the Lymphoma Research Foundation (LRF) in...

2009-01-01 23:16:26

Critically ill patients often have uncertain prognoses but families overwhelmingly wish physicians would address uncertainty candidly, U.S. researchers say. Researchers at the University of San Francisco Medical Center say past research indicating physicians' reluctance to discuss uncertain prognoses reveals a schism between families' wishes and physicians' comfort. Our interviews revealed that caregivers appear to believe that some uncertainty is unavoidable, and just the nature of life,...

e007995ed6bc39cc7ca9e0e9e14098961
2008-12-16 13:55:00

A study published on Monday suggests that although many doctors worry about breaking bad news about seriously ill patients to their kin, most family members want to know the truth. Many doctors hesitate to be fully open with critically ill patients and their families, research shows. For example, many doctors opt to give a more optimistic estimate of life expectancy, or to not discuss prognosis at all unless the patient brings it up. Studies suggest that one reason for the reluctance is that...

2008-10-24 09:00:26

Cypress Bioscience, Inc. (NASDAQ: CYPB) will launch its first two novel personalized medicine services at the American College of Rheumatology Annual Scientific Meeting in San Francisco on October 24-29, 2008. The initial personalized medicine services facilitate improved diagnostic, prognostic and therapeutic decision making for rheumatologists treating patients with rheumatoid arthritis (RA). Avise PG(SM) is a test that supports dose optimization and therapeutic decision making for...

2008-09-01 12:00:21

US-based Health Discovery Corporation has signed a licensing agreement with Smart Personalized Medicine founded by Richard Caruso, chairman and founder of Intergra Life Sciences. Pursuant to the agreement, both the companies will work together to develop a superior breast cancer prognostic test using Health Discovery Corporation's (HDC's) support vector machine technology in collaboration with MD Anderson Cancer Center. Under the terms of the agreement, HDC will receive a 15% equity...

2008-08-29 09:01:03

Health Discovery Corporation ("HDC") (OTCBB: HDVY) today announced that it has signed a Licensing Agreement with Smart Personalized Medicine, LLC, founded by Dr. Richard Caruso, Chairman and Founder of Intergra Life Sciences (NasdaqGS:IART) to work to develop a superior breast cancer prognostic test using HDC's support vector machine (SVM) technology in collaboration with MD Anderson Cancer Center. Under the terms of the Agreement, HDC will receive a 15% equity position in Smart...

2005-09-08 14:45:00

ROCHESTER, Minn. -- Mayo Clinic neurologists have created the first new, reliable and easy-to-use clinical tool in 30 years for measuring coma depth, a proposed replacement for the Glasgow Coma Scale. The new scoring system, called the FOUR (Full Outline of UnResponsiveness) Score, will be described in the October issue of Annals of Neurology, to be published online Friday, Sept. 9. When using the FOUR Score, evaluators assign a score of zero to four in each of four categories, including...